Stiolto: New drug to treat COPD
STIOLTO RESPIMAT (tiotropium bromide and olodaterol)
(sti-OL-to– RES peh mat)
Boehringer Ingelheim
Approval date: May 21, 2015
What is the drug for?
STIOLTO RESPIMAT is a long-term treatment for adults with a lung disease called COPD (chronic obstructive pulmonary disease). It is a combination of two drugs already used for COPD.
STIOLTO RESPIMAT should only be used to treat COPD and not for other breathing problems.
How is this drug used?
STIOLTO RESPIMAT is a spray inhaled through the mouth. Patients should use 2 puffs once a day at the same time each day.
What are the benefits of this drug?
STIOLTO RESPIMAT relaxes the muscles in the airways. This allows air to move easier in the lungs which helps prevent symptoms such as wheezing, cough, chest tightness, and shortness of breath.
What are the possible side effects?
The most common side effects of STIOLTO RESPIMAT include common cold, cough, and back pain.
STIOLTO RESPIMAT should never be used to treat asthma. Using STIOLTO RESPIMAT in someone with asthma can worsen the asthma and lead to death.
STIOLTO RESPIMAT can cause serious side effects, including:
- Severe allergic reactions, including rash, itchy and raised patches of skin, breathing problems, and swelling of the mouth, face, and tongue
- Sudden shortness of breath that may be life-threatening
- Heart problems including fast or irregular heartbeat, chest pain, and an increase in blood pressure
- New or worsening eye problem called narrow-angle glaucoma: symptoms can include eye pain, blurry vision, red eyes and seeing halos or colored images around lights
- New or worsening problems with urination: symptoms can include difficulty passing urine or painful urination
- Low blood potassium
- High blood sugar